Back

Procedural and angiographic outcomes of main-branch stenting with side-branch drug-coated balloon inflation strategy for bifurcation lesions

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 4 - Coronary interventions : technique Technique ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Shunsuke Kubo

Kurashiki Central Hospital, Kurashiki (Japan)

8 More presentations in this session

Presentation thumbnail
Distal left main trifurcation treatment with dedicated bifurcation stents: subgroup analysis from randomized clinical trials POLBOS I and POLBOS II.
Professor R. Gil (Warsaw, PL)
Abstract Slides
Presentation thumbnail
Impact of intravascular ultrasound and final kissing balloon dilatation on 10-year clinical outcome in percutaneous revascularization with 1-stent strategy for left main coronary artery stenosis
Professor J. Yoon (Gumi, KR)
Abstract
Presentation thumbnail
Trends and clinical outcomes of percutaneous coronary intervention for chronic total occlusions - Results from an Australian multi-centre interventional registry
Ms A. Brennan (Victoria, AU)
Abstract
Presentation thumbnail
Prediction factors for successful retrograde collateral traverse in chronic total occlusion percutaneous coronary intervention
Professor J. Liu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Prospective randomised comparison of percutaneous coronary intervention and optimal medical therapy in patients with chronic total occlusion
Doctor S. Juricic (Belgrade, RS)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Coronary interventions : technique

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Percutaneous intervention is better than surgery in real life for most patients: pro
thumbnail
Congress Session
Complex PCI in practice: tips and tricks to take home
thumbnail
Congress Presentation
Prognostic impact of intravascular imaging in percutaneous coronary intervention according to atherothrombotic risk

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources